<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E38E38FE-3A71-4E2A-886D-2190FC28D690"><gtr:id>E38E38FE-3A71-4E2A-886D-2190FC28D690</gtr:id><gtr:name>Stowers Institute of Medical Research</gtr:name><gtr:address><gtr:line1>Stowers Institute of Medical Research</gtr:line1><gtr:line2>1000E 50th Street</gtr:line2><gtr:postCode>MO 64110</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:department>Life Sciences</gtr:department><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E38E38FE-3A71-4E2A-886D-2190FC28D690"><gtr:id>E38E38FE-3A71-4E2A-886D-2190FC28D690</gtr:id><gtr:name>Stowers Institute of Medical Research</gtr:name><gtr:address><gtr:line1>Stowers Institute of Medical Research</gtr:line1><gtr:line2>1000E 50th Street</gtr:line2><gtr:postCode>MO 64110</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/3B668A64-BDB5-4CF9-8024-BD96BA4FD294"><gtr:id>3B668A64-BDB5-4CF9-8024-BD96BA4FD294</gtr:id><gtr:firstName>Jill</gtr:firstName><gtr:surname>Dixon</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0400264"><gtr:id>FA019504-D5F3-4697-B07C-B4EF2CFE13AE</gtr:id><gtr:title>The role of p63 in development of the secondary palate</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0400264</gtr:grantReference><gtr:abstractText>The roof of the mouth (the palate) develops in two halves that fuse together during a baby?s development. Currently, we do not completely understand what controls this process but we do know that cleft palate can result when it goes wrong. 

Recently, it has been found that disruption of a protein called p63, which has several different forms, can lead to cleft palate. This project is aimed at finding out how p63 functions during normal development and how this is altered in cleft palate.

We know that the levels of one form of p63 drop before fusion of the palate; we will therefore see if other forms of p63 are reduced at the same time. We will also introduce the same disruption that has been shown to cause cleft palate in man, into the p63 gene in mice, to create an animal model of cleft palate. This will allow us to look at the effects that this has on other proteins involved in cleft palate.

This research will help us to understand the role of p63 during development of the palate. In the longer term, this information will improve the way we help patients with cleft palate.</gtr:abstractText><gtr:technicalSummary>Facial clefting, encompassing clefts of the lip and palate, is one of the most common congenital birth defects in man, with an estimated incidence of 1 in 500-2500 live births. Although the aetiology of cleft palate is complex, with both genetic and environmental factors implicated, analysis of this condition affords significant opportunities to dissect the fundamental mechanisms underlying craniofacial development and analyse how these are disrupted in a common birth defect.

Recently, mutations in the transcription factor p63 have been shown to underlie five distinct autosomal dominant disorders in man, a subset of which exhibit cleft lip and palate as a defining feature. The TP63 gene is a member of the p53 family which encodes at least six protein isoforms. The use of different promoters generates TA-p63 isoforms, which have transactivating properties, or deltaN-p63 isoforms, which lack this ability. In addition, alternative splicing generates three further subtypes for each isoform. The different isoforms vary in their ability to transactivate responsive genes, control the cell cycle and induce apoptosis but the role of p63 in development of the secondary palate has not been defined.

The aims of this project are to test the hypotheses that, firstly, down-regulation of the deltaN-p63 isoform is a critical event in palate development and, secondly, that appropriate p63 function plays a critical role in the fusion and differentiation events underlying development of the secondary palate. These hypotheses will be tested via a combination of strategies using the mouse as a model organism. Firstly, the spatio-temporal expression patterns of the different isoforms will be determined. Subsequently, expression vectors will be used in combination with organ culture approaches to alter the endogenous levels of the isoforms to manipulate palatal fusion in vitro. Secondly, to address the role of p63 in development of the secondary palate in vivo, a mutation which results in cleft palate in man will be introduced into murine Tp63 via gene targeting. Tp63 mutant mice will be analysed to investigate the developmental basis of the phenotype, with emphasis placed on the analysis of palatal fusion, using a combination of histology, skeletal analysis, in vitro organ culture and analysis of cell behaviour.

This research will provide insights into the fundamental mechanisms underlying palate development, in particular the processes involved in adhesion, fusion and epithelial differentiation of the palatal shelves, and the mechanisms by which these processes are subverted, resulting in the common birth defect, cleft palate.</gtr:technicalSummary><gtr:fund><gtr:end>2008-11-28</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-03-29</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>206850</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Stowers Institute for Medical Research</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>p63 and Treacher Collins syndrome Collaboration</gtr:description><gtr:id>2A301B3D-A498-4C34-8D87-528A892AA1F2</gtr:id><gtr:impact>19107148, 18246078,16938878</gtr:impact><gtr:outcomeId>8E3324E6FA5-1</gtr:outcomeId><gtr:partnerContribution>We have had a extensive scientific collaboration at many levels, including the exchange of ideas, reagents and data</gtr:partnerContribution><gtr:piContribution>We have provided materials and data and have had considerable exchange of ideas and information</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>676000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant (co- PI)</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G0901539</gtr:fundingRef><gtr:id>BCA97A7F-27DC-44F5-8B25-D7BC20EFF770</gtr:id><gtr:outcomeId>5461d3eca73297.97470548</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>A9779A50-36CA-4087-8546-3995D06674C2</gtr:id><gtr:title>Temporal and spatial expression of Pax9 and Sonic hedgehog during development of normal mouse palates and cleft palates in TGF-beta3 null embryos.</gtr:title><gtr:parentPublicationTitle>Archives of oral biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a2ad2273e3260fbd773114dc4b237f5e"><gtr:id>a2ad2273e3260fbd773114dc4b237f5e</gtr:id><gtr:otherNames>Sasaki Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0003-9969</gtr:issn><gtr:outcomeId>BC662C41ADE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1622820C-3B3A-4E26-8DEF-EE4F1F3722BE</gtr:id><gtr:title>Treacher Collins syndrome: etiology, pathogenesis and prevention.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/86843e42b2da8afb5bfd226a5691461b"><gtr:id>86843e42b2da8afb5bfd226a5691461b</gtr:id><gtr:otherNames>Trainor PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>350058ED98D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>71356ACA-29BA-4A05-905F-54BA25AB4531</gtr:id><gtr:title>Enhanced ectodysplasin-A receptor (EDAR) signaling alters multiple fiber characteristics to produce the East Asian hair form.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d2c858e2b152d70fa4a07ead18063445"><gtr:id>d2c858e2b152d70fa4a07ead18063445</gtr:id><gtr:otherNames>Mou C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>81622309345</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A8F88F6D-797D-45A3-9419-BE468D662F48</gtr:id><gtr:title>Cooperation between the transcription factors p63 and IRF6 is essential to prevent cleft palate in mice.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d227e57074b20098bbb24de668e5088"><gtr:id>6d227e57074b20098bbb24de668e5088</gtr:id><gtr:otherNames>Thomason HA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>156B53393AE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>755F81B4-B617-4E9A-B540-BFC5948D2AB3</gtr:id><gtr:title>Integration of IRF6 and Jagged2 signalling is essential for controlling palatal adhesion and fusion competence.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e6c643a11c887cf456d82ff0c2d0f3b"><gtr:id>0e6c643a11c887cf456d82ff0c2d0f3b</gtr:id><gtr:otherNames>Richardson RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>CA58EAD774A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>94A7BE40-E9FB-431F-B851-12FAAE47648F</gtr:id><gtr:title>Facial clefting in Tp63 deficient mice results from altered Bmp4, Fgf8 and Shh signaling.</gtr:title><gtr:parentPublicationTitle>Developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d227e57074b20098bbb24de668e5088"><gtr:id>6d227e57074b20098bbb24de668e5088</gtr:id><gtr:otherNames>Thomason HA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0012-1606</gtr:issn><gtr:outcomeId>541C67143AE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF9FA8D6-A246-43CD-9FD5-74A5A28168D3</gtr:id><gtr:title>Irf6 is a key determinant of the keratinocyte proliferation-differentiation switch.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e6c643a11c887cf456d82ff0c2d0f3b"><gtr:id>0e6c643a11c887cf456d82ff0c2d0f3b</gtr:id><gtr:otherNames>Richardson RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>10D0FF0FB8D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DAB74E14-9425-41B3-AF08-E3EE20BBC9A3</gtr:id><gtr:title>Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b46ccc613e3d41afdba52c7f38c6207f"><gtr:id>b46ccc613e3d41afdba52c7f38c6207f</gtr:id><gtr:otherNames>Jones NC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>60629904275</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1467BC01-647C-4171-AC44-58202A7A26D4</gtr:id><gtr:title>Tcof1/Treacle is required for neural crest cell formation and proliferation deficiencies that cause craniofacial abnormalities.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49d422e9f2aa74165fc13d038d4bb13c"><gtr:id>49d422e9f2aa74165fc13d038d4bb13c</gtr:id><gtr:otherNames>Dixon J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>1A5418AB9D9</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0400264</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D81A471F-556F-4570-BF6A-5D197943223C</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Oral and Gastrointestinal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>